Detalles de la búsqueda
1.
Improving prescribing: a feasibility study of pharmacogenetic testing with clinical decision support in primary healthcare in Singapore.
Fam Pract
; 2022 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36417351
2.
Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults.
Pharmacogenomics J
; 19(4): 401-410, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30250149
3.
Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial.
BMC Med
; 16(1): 104, 2018 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29986700
4.
Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study.
Br J Clin Pharmacol
; 82(6): 1636-1646, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27640819
5.
Discovery of triazolone derivatives as novel, potent stearoyl-CoA desaturase-1 (SCD1) inhibitors.
Bioorg Med Chem
; 23(3): 455-65, 2015 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25555732
6.
Systematic evaluation of amide bioisosteres leading to the discovery of novel and potent thiazolylimidazolidinone inhibitors of SCD1 for the treatment of metabolic diseases.
Bioorg Med Chem Lett
; 24(2): 520-5, 2014 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24374272
7.
Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects.
Bioorg Med Chem Lett
; 24(2): 526-31, 2014 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24370012
8.
Discovery of XEN445: a potent and selective endothelial lipase inhibitor raises plasma HDL-cholesterol concentration in mice.
Bioorg Med Chem
; 21(24): 7724-34, 2013 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24211162
9.
Pharmacogenomics in Asia: a systematic review on current trends and novel discoveries.
Pharmacogenomics
; 18(9): 891-910, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28594321
10.
Opportunities and challenges in developing stearoyl-coenzyme A desaturase-1 inhibitors as novel therapeutics for human disease.
J Med Chem
; 57(12): 5039-56, 2014 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-24295027
11.
Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome.
J Med Chem
; 56(2): 568-83, 2013 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-23245208
12.
Pharmacological inhibition of stearoyl CoA desaturase in the skin induces atrophy of the sebaceous glands.
J Invest Dermatol
; 133(8): 2091-4, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23446987
Resultados
1 -
12
de 12
1
Próxima >
>>